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DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY COMMENTARIES
Defining and refining the phenotype of PRRT2 mutations
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This commentary is on the original article by Silveira-Moriyama et al.
on pages 327–334 of this issue.
Paroxysmal dyskinesias constitute a group of episode
movement disorders that have been historically classified
based on precipitant, duration, and family history. Careful
description of phenotypes has shown that classification
based on precipitant is the most powerful for predicting
features and clinical course. The three major groups are:
(1) kinesigenic – triggered by sudden movement; (2) exer-
tional – triggered by sustained exertion; (3) non-kinesigenic
– no discrete trigger but with attacks often following inges-
tion of ethanol or caffeine, or after sleep deprivation. All
three forms can exist as primary disorders or may be sec-
ondary to specific brain lesions. The primary forms typi-
cally begin in childhood and are not associated with
neurologic abnormalities between episodes. Several causa-
tive genes have been described, but the major gene respon-
sible for paroxysmal kinesigenic dyskinesia (PKD) has been
elusive until recently.1
Silveira-Moriyama et al.2 describe the clinical features of
children with PKD and PRRT2 gene mutations. Since
discovery of the association between PRRT2 mutations and
PKD, there has been substantial progress in further defin-
ing the phenotypic spectrum of these mutations. Mutations
in the PRRT2 gene may cause PKD, infantile convulsions,
or familial hemiplegic migraine.2–4 PRRT2 mutations may
also cause episodic ataxia5 or febrile seizures.6
In addition to contributions toward better understanding
of the disorder and its prognosis, the findings of Silviera-
Moriyama et al.2 raise important conceptual questions
about the pathophysiology of paroxysmal disorders. Early
reports of paroxysmal dyskinesias raised the question of
whether they might be a form of epilepsy, yet surface
electroencephalography is normal during attacks. By con-
vention, seizures are viewed as cortical phenomena due to
the paroxysmal discharge of neurons. However, it is rea-
sonable to hypothesize that paroxysmal dyskinesias are due
to paroxysmal discharge of subcortical neurons. Supporting
this notion is the exquisite clinical response of PKD to low
doses of anticonvulsant medications such as carbamazepine
or phenytoin. Can some forms of hemiplegic migraine also
result from paroxysmal neuronal discharge? Or can PRRT2
mutations lead to paroxysmal of neuronal depression?
Further study of neuronal function in the setting of PRRT2
mutations is likely to shed light on the pathophysiology of
many paroxysmal disorders including seizures, migraine,
paroxysmal movement disorders, and paroxysmal ataxia.
REFERENCES
1. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing
identifies truncating mutations in PRRT2 that cause
paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43:
1252–5.
2. Silveira-Moriyama L, Gardiner A, Meyer E, et al. Clini-
cal features of childhood onset paroxysmal kinesigenic
dyskinesia with PRRT2 gene mutations. Dev Med Child
Neurol 2013; 55: 327–34.
3. Cloarec R, Bruneau N, Rudolf G, et al. PRRT2 links
infantile convulsions and paroxysmal dyskinesia with
migraine. Neurology 2012; 79: 2097–103.
4. Marini C, Conti V, Mei D, et al. PRRT2 mutations in
familial infantile seizures, paroxysmal dyskinesia, and
hemiplegic migraine. Neurology 2012; 79: 2109–14.
5. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2
gene mutations: from paroxysmal dyskinesia to episodic
ataxia and hemiplegic migraine. Neurology 2012; 79:
2115–21.
6. Scheffer IE, Grinton BE, Heron SE, et al. PRRT2 phe-
notypic spectrum includes sporadic and fever-related
infantile seizures. Neurology 2012; 79: 2104–8.
Coexistent childhood renovascular and cerebrovascular disease
SARAH BUERKI | MAJA STEINLIN
Department of Neuropaediatrics, Development and Rehabilitation, University
Children’s Hospital, Inselspital, Bern, Switzerland.
doi: 10.1111/dmcn.12090
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In their retrospective case note and imaging review of 34
children, Willsher et al.1 point to the importance and fre-
quently neglected association of coexisting renovascular
disease and steno-occlusive cerebrovascular problems such
as moyamoya or other complex occlusive cerebrovascular
disease (OCVD). The patients were retrospectively identi-
fied having been investigated with cerebral and renal digi-
tal subtraction catheter angiography. The majority (11/14)
with OCVD and about 20% of children with moyamoya
had a renal artery stenosis. Accompanying hypertension
could be detected in 20 out of 34, although whether it
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was of renal, cerebral, or combined origin cannot be
defined.
Amlie-Lefond et al.2 recently described in a large cohort
of 525 patients of the International Pediatric Stroke Study
different types and predictors of cerebral arteriopathy in
children with arterial ischaemic stroke. An arteriopathy was
identified on vascular imaging in over half of the patient
group. Focal cerebral arteriopathy was the most common
type, followed by moyamoya (20%), and among others two
patients with fibromuscular dysplasia, and 12% with vascu-
litis. These different subgroups can have hypertension,
whether this is conditional on cerebral hypoperfusion or in
connection with a renovascular problem. For instance,
many vasculitides can cause renovascular hypertension as
well.2 Thus patients with arterial ischaemic stroke and vas-
culopathies should be examined more carefully in general
regarding systemic vascular involvement.
Willsher et al. categorized 14 out of 34 children with
complex OCVD defined as stenosis or occlusion of more
than one cerebral or cervical artery, not meeting the crite-
ria for moyamoya. Apparently it was not possible to cate-
gorize them using the criteria proposed by Sebire et al.3
However, it could be that the new classification system
proposed by Bernard et al.4 gives the opportunity to clas-
sify them as ‘aortic/cervical arteriopathy’ or ‘multi-facto-
rial’. Besides that, it considers whether children with
arterial ischaemic stroke and concurrent renovascular
involvement who do not fulfil the criteria for Takayasu
arteritis or fibromuscular dysplasia should be classified sep-
arately.
The fact that accurate blood pressure measuring is fre-
quently neglected in children is important. Although treat-
ments have to be considered very cautiously (compensatory
cerebral hypertension), there is a diagnostic impact. Com-
pensatory hypertension might also be easy to follow as an
important marker for beneficial effects of treatment
approaches to the vascular problem.
The comparison to the study of Togao et al.5 has to be
viewed critically as the age group (2–48years for Togao
et al.’s study) is different; but as the underlying moyamoya
is a progressive problem it is important to point out that
two of four patients with renal artery stenosis were of
childhood age. Compared with the data of Willsher et al.
this is a significantly lower percentage and poses the ques-
tion of whether the likelihood of renal abnormalities is dif-
ferent in moyamoya syndrome and moyamoya disease. The
paper by Willsher et al. underscores the importance of
searching for hypertension and renovascular abnormalities
in children with OCVD, but also in those with moymoya
(despite being less frequent), although the group of
described patients is heterogeneous and highly selected.
On the other hand, the level of suspicion regarding cere-
brovascular diseases in patients with renovascular hyperten-
sion or systemic vascular disorders as fibromuscular disease
has to be high.
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Progressive or chronic cerebellar ataxia is often a troubling
diagnostic challenge both in adults and children. In patients
with adult onset ataxias, both genetic and acquired diseases
merit consideration once overt structural causes of ataxia are
excluded by imaging. Such disorders have cerebellar deficits
as a core feature, with added motor and sensory signs that
may indicate specific etiologies. Genetic and immune testing
often allows very specific diagnoses but a substantial number
of cases remain not fully characterized. The heterogeneity of
genetic causes of ataxia and phenotypic heterogeneity result-
ing from particular gene mutations lead to difficulties in
choosing the right tests and their interpretation.
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